Your browser doesn't support javascript.
SARS-CoV-2: Remarks on the COVID-19 Pandemic.
Piasecki, Egbert.
  • Piasecki E; Laboratory of Virology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland. egbert.piasecki@hirszfeld.pl.
Arch Immunol Ther Exp (Warsz) ; 68(6): 35, 2020 Nov 13.
Article in English | MEDLINE | ID: covidwho-983490
ABSTRACT
The COVID-19 pandemic developing rapidly in 2020 is triggered by the emergence of a new human virus-SARS-CoV-2. The emergence of a new virus is not an unexpected phenomenon and has been predicted for many years. Since the virus has spread all over the world, it will be very difficult or even impossible to eradicate it. A necessary condition for complete or partial elimination of the virus is to have an effective vaccine. It is possible that SARS-CoV-2 will become milder in the next few years and COVID-19 will then only threaten individuals from risk groups.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: Arch Immunol Ther Exp (Warsz) Year: 2020 Document Type: Article Affiliation country: S00005-020-00600-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: Arch Immunol Ther Exp (Warsz) Year: 2020 Document Type: Article Affiliation country: S00005-020-00600-7